Andrew Camp1, Sarah R Wellik2, Jonathan H Tzu3, William Feuer3, Kristopher L Arheart4, Ananth Sastry3, Anat Galor5. 1. Miami Veterans Administration Medical Center, 1201 NW 16th Street, Miami, FL 33125, United States; Bascom Palmer Eye Institute, University of Miami, 900 NW 17th Street, Miami, FL 33136, United States. 2. Miami Veterans Administration Medical Center, 1201 NW 16th Street, Miami, FL 33125, United States; Bascom Palmer Eye Institute, University of Miami, 900 NW 17th Street, Miami, FL 33136, United States. Electronic address: swellik@med.miami.edu. 3. Bascom Palmer Eye Institute, University of Miami, 900 NW 17th Street, Miami, FL 33136, United States. 4. Department of Epidemiology, University of Miami, 1120 NW 14th Street (R669), Miami, FL 33136, United States. 5. Miami Veterans Administration Medical Center, 1201 NW 16th Street, Miami, FL 33125, United States; Bascom Palmer Eye Institute, University of Miami, 900 NW 17th Street, Miami, FL 33136, United States. Electronic address: agalor@med.miami.edu.
Abstract
PURPOSE: To evaluate the frequency of ocular surface symptoms and their potential impact on dry eye specific quality of life (QoL) in patients using versus not using glaucoma medications. MATERIAL AND METHODS: The study was a single-center, cross-sectional survey of patients seen at the Miami Veterans Affairs (VA) ophthalmology and optometry clinics from June to August, 2010. Patients were invited to complete the Dry Eye Questionnaire 5 (DEQ5) and the Impact of Dry Eye on Everyday Life (IDEEL) at their visit. Of 1348 patients seen in the Miami VA eye clinics during this three-month period, 467 patients completed the DEQ5 and 391 responded to both questionnaires. Outcome measures comprised ocular surface symptoms and their impact on dry eye specific QoL in patients using versus not using glaucoma drops. RESULTS: An increasing number of glaucoma drops was significantly associated with an increased percentage of severe dry eye symptoms: no medications, 25% (n=89/353); 1 or 2 medications, 27% (n=17/62); 3 or more medications, 40% (n=21/52); p=0.03 (Armitage's test for linear-trend in proportions). There was an association between increasing number of drops and decreasing emotional well-being scores (linear p<0.001; quadratic p=0.029). Black patients had higher dry eye symptoms and lower emotional QoL scores compared to white patients at every level of medication use. CONCLUSION: An increasing number of glaucoma medications were associated with an increased frequency of severe dry eye symptoms and decreased emotional QoL. Additionally, dry eye specific emotional QoL was more severely affected in black versus white patients. Published by Elsevier Ltd.
PURPOSE: To evaluate the frequency of ocular surface symptoms and their potential impact on dry eye specific quality of life (QoL) in patients using versus not using glaucoma medications. MATERIAL AND METHODS: The study was a single-center, cross-sectional survey of patients seen at the Miami Veterans Affairs (VA) ophthalmology and optometry clinics from June to August, 2010. Patients were invited to complete the Dry Eye Questionnaire 5 (DEQ5) and the Impact of Dry Eye on Everyday Life (IDEEL) at their visit. Of 1348 patients seen in the Miami VA eye clinics during this three-month period, 467 patients completed the DEQ5 and 391 responded to both questionnaires. Outcome measures comprised ocular surface symptoms and their impact on dry eye specific QoL in patients using versus not using glaucoma drops. RESULTS: An increasing number of glaucoma drops was significantly associated with an increased percentage of severe dry eye symptoms: no medications, 25% (n=89/353); 1 or 2 medications, 27% (n=17/62); 3 or more medications, 40% (n=21/52); p=0.03 (Armitage's test for linear-trend in proportions). There was an association between increasing number of drops and decreasing emotional well-being scores (linear p<0.001; quadratic p=0.029). Black patients had higher dry eye symptoms and lower emotional QoL scores compared to white patients at every level of medication use. CONCLUSION: An increasing number of glaucoma medications were associated with an increased frequency of severe dry eye symptoms and decreased emotional QoL. Additionally, dry eye specific emotional QoL was more severely affected in black versus white patients. Published by Elsevier Ltd.
Entities:
Keywords:
Dry eye syndrome; Glaucoma; Quality of life
Authors: Gemma C M Rossi; Gian Maria Pasinetti; Luigia Scudeller; Rosella Radaelli; Paolo Emilio Bianchi Journal: Eur J Ophthalmol Date: 2011 Jul-Aug Impact factor: 2.597
Authors: Jose Delgado; Elizabeth A Jacobs; Daniel T Lackland; Denis A Evans; Carlos F Mendes de Leon Journal: J Gerontol A Biol Sci Med Sci Date: 2012-04-10 Impact factor: 6.053
Authors: Andrew S Camp; Christopher P Long; Anat Galor; Maya Yamane; James A Proudfoot; Robert N Weinreb Journal: J Glaucoma Date: 2022-03-18 Impact factor: 2.290
Authors: Jose Maria Martinez-de-la-Casa; Carlos Oribio-Quinto; Almudena Milans-Del-Bosch; Pilar Perez-Garcia; Laura Morales-Fernandez; Javier Garcia-Bella; Jose Manuel Benitez-Del-Castillo; Julian Garcia-Feijoo; David P Piñero Journal: Eye Vis (Lond) Date: 2022-04-01
Authors: María Carmen Sánchez-González; Raúl Capote-Puente; Marta-C García-Romera; Concepción De-Hita-Cantalejo; María-José Bautista-Llamas; Carmen Silva-Viguera; José-María Sánchez-González Journal: Front Med (Lausanne) Date: 2022-08-10